Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Diplomat Pharmacy, Inc. (DPLO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/10/2020 8-K Quarterly results
12/30/2019 8-K Quarterly results
12/09/2019 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "AGREEMENT AND PLAN OF MERGER",
"Consent Letter Agreement with Brian Griffin",
"Consent Letter Agreement with Dan Davison",
"Tender and Support Agreement",
"Diplomat, OptumRx Combining to Advance Access to Specialty Pharmacy Care and Infusion Services, Improve Health Outcomes"
11/12/2019 8-K Quarterly results
08/09/2019 8-K Quarterly results, Credit agreement amendment
Docs: "Amendment No. 1 to Credit Agreement, by and among the Company, the Lenders and JPMorgan Chase Bank, N.A., as Administrative Agent, effective August 6, 2019",
"Diplomat Announces 2nd Quarter Financial Results Updates 2019 Guidance",
"Supplemental slide presentation for the quarter ended June 30, 2019",
"###"
07/26/2019 8-K Unregistered Sales of Equity Securities
06/21/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/07/2019 8-K Submission of Matters to a Vote of Security Holders
05/07/2019 8-K Quarterly results
Docs: "Diplomat Announces 1st Quarter Financial Results",
"Supplemental slide presentation for the quarter ended March 31, 2019"
05/06/2019 8-K Appointed COO
Docs: "###"
04/22/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Notice of Pendency and Proposed Settlement of Stockholder Action",
"Stipulation of Settlement"
03/15/2019 8-K Quarterly results
Docs: "Employment Agreement, effective April 8, 2019, by and between the Company and Dan Davison",
"Separation and Release Agreement, by and between the Company and Atul Kavthekar",
"Diplomat Announces 4th Quarter and 2018 Year End Financial Results; Provides Revised 2019 Guidance",
"Supplemental slide presentation for the fourth quarter and year ended December 31, 2018",
"###"
03/13/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Diplomat Pharmacy, Inc. Executive Severance Plan"
02/28/2019 8-K Quarterly results
02/22/2019 8-K Quarterly results
01/07/2019 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Separation and Release Agreement, by and between the Company and Joel Saban",
"###",
"Supplemental slide presentation dated January 7, 2019, regarding financial guidance"
11/06/2018 8-K Quarterly results
Docs: "Diplomat Announces 3rd Quarter Financial Results",
"Supplemental slide presentation for the quarter ended September 30, 2018"
08/06/2018 8-K Quarterly results
Docs: "Diplomat Announces 2nd Quarter Financial Results",
"Supplemental slide presentation for the quarter ended June 30, 2018"
07/27/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Severance Benefits Agreement, by and between the Company and Atul Kavthekar"
06/15/2018 8-K Submission of Matters to a Vote of Security Holders
05/08/2018 8-K Quarterly results
Docs: "Diplomat Announces Strong 1st Quarter Financial Results",
"Diplomat Pharmacy in Final Stages of CEO Search Process Jeff Park Resigns Voluntarily as Interim CEO"
04/06/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Opinion of Honigman Miller Schwartz and Cohn LLP"
03/29/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of Restricted Stock Unit Award Agreement (Performance-Based)",
"Form of Stock Option Award Agreement (Time-Based)"
02/26/2018 8-K Quarterly results
Docs: "Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance"
01/05/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Bylaws of Diplomat Pharmacy, Inc",
"Diplomat Initiates CEO Transition; Reaffirms 2017 Guidance and Provides Preliminary 2018 Outlook",
"Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook"
12/21/2017 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "Credit Agreement, by and among the Company, the Lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent",
"Guarantee and Collateral Agreement, by and among the Company, the other Loan Parties, and JPMorgan Chase Bank, N.A., as Administrative Agent",
"###"
11/16/2017 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Securities Purchase Agreement and Plan of Merger by and among Diplomat Pharmacy, Inc., LDI Holding Company, LLC and the other parties named therein",
"Commitment Letter by and among Diplomat Pharmacy, Inc., JPMorgan Chase Bank, N.A., and Capital One, National Association",
"Diplomat to Acquire LDI Integrated Pharmacy Services",
"Additional information regarding the pending acquisition of LDI"
11/06/2017 8-K Quarterly results
Docs: "Diplomat Announces 3rd Quarter Financial Results"
08/07/2017 8-K Quarterly results
06/13/2017 8-K Form 8-K - Current report
05/08/2017 8-K Form 8-K - Current report
04/13/2017 8-K Form 8-K - Current report
04/11/2017 8-K Form 8-K - Current report
04/07/2017 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy